Randy Guggenheimer
2021
In 2021, Randy Guggenheimer earned a total compensation of $3.6M as Chief Business Officer at NRX Pharmaceuticals.
Compensation breakdown
| Option Awards | $3,443,247 |
|---|---|
| Salary | $143,846 |
| Total | $3,587,093 |
Guggenheimer received $3.4M in option awards, accounting for 96% of the total pay in 2021.
Guggenheimer also received $143.8K in salary.
Rankings
In 2021, Randy Guggenheimer's compensation ranked 3,716th out of 12,415 executives tracked by ExecPay. In other words, Guggenheimer earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,716 out of 12,415 | 70th |
Division Manufacturing | 1,509 out of 5,505 | 73rd |
Major group Chemicals And Allied Products | 614 out of 2,375 | 74th |
Industry group Drugs | 545 out of 2,096 | 74th |
Industry Pharmaceutical Preparations | 383 out of 1,546 | 75th |
Source: SEC filing on June 17, 2022.
Guggenheimer's colleagues
We found three more compensation records of executives who worked with Randy Guggenheimer at NRX Pharmaceuticals in 2021.